08:23 AM EST, 11/07/2024 (MT Newswires) -- Becton Dickinson ( BDX ) guided for mostly upbeat earnings in fiscal 2025 after results for the medical technology company topped Wall Street's expectations in the final quarter of the prior year.

The maker of diagnostic and lab-testing devices projected revenue of $21.9 billion to $22.1 billion for fiscal 2025, it said on Thursday. The consensus on Capital IQ is for $21.77 billion. Adjusted earnings are pegged at $14.25 to $14.60 a share, mostly ahead of the current Street view for $14.30.

"Our growth strategy remains focused on delivering solutions for our customers that leverage significant shifts in technology, like biologics, AI and automation, that are revolutionizing patient care," Chief Executive Tom Polen said in a statement.

The outlook comes after fiscal fourth-quarter revenue rose 6.9% year over year to $5.44 billion, besting the Capital IQ consensus for $5.38 billion. Adjusted earnings climbed to $3.81 a share from $3.42 a year ago, topping Street projections for $3.77.

The company's medical segment, which includes the division formed after Becton Dickinson ( BDX ) took over Edwards Lifesciences' (EW) critical care segment, was up 11% to $2.84 billion. The $4.2 billion acquisition was completed in September.

Life sciences revenue was slightly higher, rising 0.7% to $1.34 billion, with the growth led by integrated diagnostic solutions, the firm said. The biosciences business unit faced "lower market demand" for its research instruments, Becton Dickinson ( BDX ) said. Revenue in the interventional segment, which includes surgery devices along with urology and critical care, rose 4.7% to $1.26 billion.

International sales grew at a slower pace than the US, rising 5.1% over the domestic pace of 8.3%. Becton Dickinson ( BDX ) said its organic revenue guidance for fiscal 2025, which puts growth in a range of 4% to 4.5%, reflects expected declines in China as well as "market dynamics" in bioscience and pharma. In fiscal 2024, organic revenue grew 5%.

Price: 237.23, Change: +1.99, Percent Change: +0.85